News report
綠葉製藥肺癌新藥Zepzelca在港澳上市：為小細胞肺癌患者帶來新希望
癌症患者免疫力下降易生蛇，症狀包括神經痛、水泡，易與癌症痛症混淆。李宇聰醫生建議化療前接種新一代重組生蛇疫苗，非活體疫苗更安全，保護率87.7%，保護...
Read more >>
Yen Cheng-kuo passed away from lung adenocarcinoma | Dr. Li Yu Chung, Jacky analyzes 6 high-risk factors, survival rates, and the latest treatment options
台灣男星顏正國肺腺癌離世，確診不足1年。香港聯合腫瘤中心李宇聰醫生解析本港肺癌致命率達66%，每年5,707人確診。詳解6大高危人士、3種警號徵狀、4...
Read more >>
Sing Tao Front Page Exclusive Interview: 55% of New Lung Cancer Cases Are at Advanced Stages, Personalized Therapy Helps Reduce Recurrence Risk
Sing Tao Daily invited Dr. Li Yu Chung, Jacky to analyze lung cancer treatment trends. In 2022, 55% of new lung cancer cases reached stage IV, with a stage I survival rate of 72.4% compared to stage III's 24.6%. The Hong Kong United Cancer Centre provides genetic testing guidance...
Read more >>
TOPick Exclusive Interview: New Breakthrough in Stage 4 Lung Adenocarcinoma Treatment – Third-Generation Targeted Therapy Extends Survival by 38.6 Months
TOPick of Hong Kong Economic Journal invited Dr. Li Yu Chung, Jacky to analyze treatment regimens for lung adenocarcinoma. The median overall survival of third-generation targeted drugs reaches 38.6 months, while the efficacy rate of novel antibody-drug conjugate (ADC) targeted drugs is as high as 90% among patients with no smoking history. Hong Kong...
Read more >>
Am730_genic test is so useful _ Help you take the right medicine to treat metastatic colorectal cancer
Am730_genic test is so useful _ Help you take the right medicine to treat metastatic colorectal cancer
Read more >>
Am730 – Amgen's Precision Personalized Treatment: Bringing More Hope to Patients with Advanced Lung Cancer
Oriental Daily News_genic Testing Etiology MET Lung Cancer New News
Read more >>